Cargando…
Remdesivir for Outpatient Management: Time to Wait, Not to Act
Autor principal: | Mohapatra, Prasanta Raghab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893308/ https://www.ncbi.nlm.nih.gov/pubmed/35249635 http://dx.doi.org/10.1016/j.amjmed.2021.07.009 |
Ejemplares similares
-
Comparison of Conventional versus Molecular Semi-Quantitative Assay in Presumptive Pulmonary Tuberculosis Cases: A Study from Eastern India
por: Purohit, Geetarani, et al.
Publicado: (2020) -
Remdesivir: Remedy the world is waiting for?
por: Suranagi, Umesh Devappa, et al.
Publicado: (2020) -
Letter in Response to “Melioidosis in a Tertiary Care Center from South India: A 5-year Experience
por: Behera, Bijayini, et al.
Publicado: (2023) -
Metallo-β-lactamase 1 - why blame New Delhi & India?
por: Mohapatra, Prasanta Raghab
Publicado: (2013) -
Community-Acquired burkholderia cepacia complex (BCC) pneumonia in a lung cancer patient on erlotinib
por: Mohapatra, Prasanta Raghab, et al.
Publicado: (2023)